daily coverage of the optics & photonics industry and the markets that it serves
'Pre-alpha' development
Rockley says that its 'spectrophotometer-on-a-chip' modules are currently at the 'pre-alpha' stage of development, meaning that the company is working to optimize algorithms that will eventually provide consumers with data on key biomarkers such as blood pressure and blood glucose concentrations. Trials of the hardware should take place over the next couple of years, with the potential to appear in full consumer products in 2023. Photo: Rockley Photonics.
Copyright © 2022 SPIE EuropeDesigned by Kestrel Web Services